E- Poster / 編號
2026PA-A05
Category / 徵稿主題
02 藥物科學類：藥物化學、藥理探索、天然藥物、中草藥
Title / 題目
Development of a salicylanilide derivative against KRAS mutant cancer cells by targeting STAT3 signaling pathways
Author / 作者群
林靜約1,2,溫志宏3,4,楊欣瑜5,林于琇5,邱敏華5,Dharshana Venkidupathy6,施柏漳5
Affiliation / 服務單位
1. Kaohsiung Armed Forces General Hospital, Kaohsiung, 80284, Taiwan
2. National Defense Medical University, Taipei 11490, Taiwan
3. Department of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
4. National Museum of Marine Biology & Aquarium, Pingtung, 944, Taiwan
5. Institute of BioPharmaceutical Sciences, National Sun Yat-sen University, Kaohsiung 804, Taiwan
6. Faculty of Engineering, Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu 641021, India
2. National Defense Medical University, Taipei 11490, Taiwan
3. Department of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
4. National Museum of Marine Biology & Aquarium, Pingtung, 944, Taiwan
5. Institute of BioPharmaceutical Sciences, National Sun Yat-sen University, Kaohsiung 804, Taiwan
6. Faculty of Engineering, Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu 641021, India
